| 1 |
Bell SM, Lam DH, Kearney K, et al. Management of refractory ventricular fibrillation (prehospital and emergency department) [J]. Cardiol Clin, 2018, 36(3): 395-408.
|
| 2 |
Waldmann V, Bougouin W, Karam N, et al. Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation [J]. Eur Heart J, 2018, 39(21): 1981-1987.
|
| 3 |
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association [J]. Circulation, 2023, 147(8): e93-e621.
|
| 4 |
Wang CH, Chang WT, Huang CH, et al. Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia [J]. J Formos Med Assoc, 2020, 119(1 Pt 2): 327-334.
|
| 5 |
Haskell SE, Hoyme D, Zimmerman MB, et al. Association between survival and number of shocks for pulseless ventricular arrhythmias during pediatric in-hospital cardiac arrest in a national registry [J]. Resuscitation, 2024, 198: 110200.
|
| 6 |
Lawley CM, Tanous D, O'Donnell C, et al. Ten years of percutaneous pulmonary valve implantation in Australia and New Zealand [J]. Heart Lung Circ, 2022, 31(12): 1649-1657.
|
| 7 |
Kumar A, Avishay DM, Jones CR, et al. Sudden cardiac death: epidemiology, pathogenesis and management [J]. Rev Cardiovasc Med, 2021, 22(1): 147-158.
|
| 8 |
Holmstrom L, Chugh SS. How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation [J]. Eur Heart J, 2022, 43(47): 4897-4898.
|
| 9 |
Franco D, Goslar T, Radsel P, et al. Coronary features across the spectrum of out-of-hospital cardiac arrest with ST-elevation myocardial infarction (CAD-OHCA study) [J]. Resuscitation, 2023, 193: 109981.
|
| 10 |
Tseng ZH, Nakasuka K. Out-of-hospital cardiac arrest in apparently healthy, young adults [J]. JAMA, 2025, 333(11): 981-996.
|
| 11 |
Clay-Weinfeld K, Callans M. Common postcardiothoracic surgery arrhythmias [J]. Crit Care Nurs Clin North Am, 2019, 31(3): 367-388.
|
| 12 |
Zhou N, Gong J, Liang X, et al. Preoperative risk prediction score for and in-hospital clinical outcomes of reperfusion ventricular fibrillation after release of aortic cross-clamps: a retrospective study [J]. J Cardiothorac Vasc Anesth, 2023, 37(1): 127-134.
|
| 13 |
Murphy TW, Windermere S, Morris T, et al. Risk and ROSC - legal implications of bystander CPR [J]. Resuscitation, 2020, 151: 99-102.
|
| 14 |
Ong M, Perkins GD, Cariou A. Out-of-hospital cardiac arrest: prehospital management [J]. Lancet, 2018, 391(10124): 980-988.
|
| 15 |
Lamhaut L, Tea V, Raphalen JH, et al. Coronary lesions in refractory out of hospital cardiac arrest (OHCA) treated by extra corporeal pulmonary resuscitation (ECPR) [J]. Resuscitation, 2018, 126: 154-159.
|
| 16 |
Kato Y, Kuriyama A, Hata R, et al. Extracorporeal membrane oxygenation for hypokalemia and refractory ventricular fibrillation associated with caffeine intoxication [J]. J Emerg Med, 2020, 58(1): 59-62.
|
| 17 |
Lemery R. Cardiac neuromodulation and neurocardiology [J]. J Cardiovasc Electrophysiol, 2025, 36(4): 863-873.
|
| 18 |
Cheskes S, Drennan IR, Turner L, et al. The impact of alternate defibrillation strategies on shock-refractory and recurrent ventricular fibrillation: a secondary analysis of the DOSE VF cluster randomized controlled trial [J]. Resuscitation, 2024, 198: 110186.
|
| 19 |
Cheskes S, Dorian P, Feldman M, et al. Double sequential external defibrillation for refractory ventricular fibrillation: the DOSE VF pilot randomized controlled trial [J]. Resuscitation, 2020, 150: 178-184.
|
| 20 |
Delorenzo A, Nehme Z, Yates J, et al. Double sequential external defibrillation for refractory ventricular fibrillation out-of-hospital cardiac arrest: a systematic review and meta-analysis [J]. Resuscitation, 2019, 135: 124-129.
|
| 21 |
Miraglia D, Miguel LA, Alonso W. Double defibrillation for refractory in- and out-of-hospital cardiac arrest: a systematic review and meta-analysis [J]. J Emerg Med, 2020, 59(4): 521-541.
|
| 22 |
Norvik A, Unneland E, Bergum D, et al. Pulseless electrical activity in in-hospital cardiac arrest - a crossroad for decisions [J]. Resuscitation, 2022, 176: 117-124.
|
| 23 |
Holmberg M, Holmberg S, Herlitz J. Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in Sweden [J]. Resuscitation, 2000, 44(1): 7-17.
|
| 24 |
Bartos JA, Voicu S, Matsuura TR, et al. Role of epinephrine and extracorporeal membrane oxygenation in the management of ischemic refractory ventricular fibrillation: a randomized trial in pigs [J]. JACC Basic Transl Sci, 2017, 2(3): 244-253.
|
| 25 |
Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: adult advanced cardiovascular life support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care [J]. Circulation, 2015, 132(18 Suppl 2): S444-464.
|
| 26 |
Perman SM, Elmer J, Maciel CB, et al. 2023 American Heart Association Focused Update on adult advanced cardiovascular life support: an update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care [J]. Circulation, 2024, 149(5): e254-e273.
|
| 27 |
Wagner D, Kronick SL, Nawer H, et al. Comparative effectiveness of Amiodarone and Lidocaine for the treatment of in-hospital cardiac arrest [J]. Chest, 2023, 163(5): 1109-1119.
|
| 28 |
Valdes SO, Donoghue AJ, Hoyme DB, et al. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation [J]. Resuscitation, 2014, 85(3): 381-386.
|
| 29 |
Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial [J]. Lancet, 2020, 396(10265): 1807-1816.
|
| 30 |
Lüsebrink E, Binzenhöfer L, Kellnar A, et al. Venting during venoarterial extracorporeal membrane oxygenation [J]. Clin Res Cardiol, 2023, 112(4): 464-505.
|